Renal medullary carcinoma (RMC) is a rare and extremely aggressive kidney cancer. In the United States, it is diagnosed most frequently among young Black men who carry the sickle cell trait, an inherited blood mutation.

But do you have to carry the sickle cell trait to develop renal medullary carcinoma? How else does it differ from other kidney cancers? And, what are the latest advances in its diagnosis and treatment?

Here...